SALTS AND POLYMORPHIC FORMS OF MENNIN INHIBITORS AND PHARMACEUTICAL COMPOSITIONS THEREOF

Abstract

The present invention relates to a salt and salt forms of Compound A. It also relates to pharmaceutical compositions containing salt forms or citrate salts of Compound A and to the therapeutic use of said salts, salt forms, and compositions thereof in the treatment of cancer. A monohydrate monocitrate salt of Form A of Compound A, wherein Compound A is of the following formula characterized by PXRD peaks at 11.8 °2(theta) and 16.9 °2(theta) (±0.2 °2(theta); ±0.1 °2(theta); or ±0.0 °2(theta); Cu K(alpha)1 radiation).